Here are the 20 worst-performing stocks among the S&P 500 in 2023
By Philip van Doorn
The biggest losers of the year included Pfizer, Dollar General, Enphase Energy and Walgreens
(Updated with Friday's closing prices.)
The U.S. stock market staged a remarkable rally in 2023, but 178 stocks in the S&P 500 were still down for the year.
Here's a roundup of how well the 11 sectors of the S&P 500 fared, with broad indexes below:
Healthcare 2023 price change 2022 price change Price change since end of 2021 Forward P/E Forward P/E at end of 2022 Forward P/E at end of 2023 Information Technology 56.4% -28.9% 11.5% 26.7 20.0 28.2 Communication Services 54.4% -40.4% -7.6% 17.4 14.3 21.0 Consumer Discretionary 41.0% -37.6% -11.4% 26.2 21.7 34.7 Industrials 16.0% -7.1% 8.0% 20.0 18.7 22.0 Materials 10.2% -14.1% -4.9% 19.5 15.8 16.6 Financials 9.9% -12.4% -3.4% 14.6 13.0 16.3 Real Estate 8.3% -28.4% -21.6% 18.3 16.9 24.7 Health Care 0.3% -3.6% -3.3% 18.2 17.7 17.3 Consumer Staples -2.2% -3.2% -5.4% 19.3 20.6 21.4 Energy -4.8% 59.0% 51.8% 10.9 9.8 11.1 Utilities -10.2% -1.4% -11.4% 15.9 18.7 20.4 S&P 500 24.2% -19.4% 0.4% 19.7 16.8 21.6 Dow Jones Industrial Average 13.7% -8.8% 3.8% 17.6 16.6 18.9 Nasdaq Composite 43.4% -33.1% -3.5% 26.9 22.6 32.0 Nasdaq-100 53.8% -33.0% 3.5% 26.3 20.9 30.3 Source: FactSet
All price changes in this article exclude dividends.
Also read: These 20 stocks soared the most in 2023
Because the 2023 rally followed a dismal 2022, the table includes price changes from the end of 2021, as well as forward price-to-earnings values based on current data and those at the end of 2022 and 2021.
Here are the 20 stocks in the S&P 500 whose prices fell the most in 2023:
Estée Lauder Cos. Inc. Class A Ticker 2023 price change 2022 price change Price change since end of 2021 Forward P/E Forward P/E at end of 2022 Forward P/E at end of 2021 Enphase Energy Inc. ENPH -50% 45% -28% 31.9 48.8 60.1 FMC Corp. FMC -49% 14% -43% 14.1 14.9 14.2 Dollar General Corp. DG -45% 4% -42% 18.3 20.2 21.2 Moderna Inc. MRNA -45% -29% -61% N/A 38.7 9.3 Pfizer Inc. PFE -44% -13% -51% 12.5 10.5 9.7 Estee Lauder Cos. Inc. Class A EL -41% -33% -60% 45.6 39.8 46.4 Paycom Software Inc. PAYC -33% -25% -50% 25.4 42.3 73.9 Albemarle Corp. ALB -33% -7% -38% 11.2 7.8 38.9 AES Corp. AES -33% 18% -21% 10.2 16.4 14.7 Etsy Inc. ETSY -32% -45% -63% 31.3 44.9 64.0 V.F. Corp. VFC -32% -62% -74% 10.5 11.9 20.4 Illumina Inc. ILMN -31% -47% -63% 152.3 66.0 90.2 Walgreens Boots Alliance Inc. WBA -30% -28% -50% 7.7 8.1 10.4 Hormel Foods Corp. HRL -30% -7% -34% 20.3 23.9 24.6 Bristol-Myers Squibb Co. BMY -29% 15% -18% 7.1 9.0 7.9 NextEra Energy Inc. NEE -27% -10% -35% 17.9 27.0 34.0 Eversource Energy ES -26% -8% -32% 13.6 19.2 22.1 Devon Energy Corp. DVN -26% 40% 3% 7.6 7.0 8.4 Insulet Corp. PODD -26% 11% -18% 87.4 260.4 194.9 Conagra Brands Inc. CAG -26% 13% -16% 10.5 15.2 13.3 Source: FactSet
Click on the tickers for more about each company.
Click here for Tomi Kilgore's detailed guide to the wealth of information available for free on the MarketWatch quote page.
Don't miss: Nvidia tops list of Wall Street's 20 favorite stocks for 2024
-Philip van Doorn
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
12-30-23 0549ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
Six Sports Betting and iGaming Stocks Trading at a Discount
-
4 Predictions for Stocks and the Economy for the Second Half of 2024
-
What Broadening Rally? AI Stocks Dominate Again In Q2
-
After Earnings, Is Nike Stock a Buy, a Sell, or Fairly Valued?
-
Worst-Performing Stock ETFs of the Quarter
-
Top-Performing Stock ETFs of the Quarter
-
Q2 In Review and Q3 2024 Market Outlook
-
5 Stocks to Buy for 3Q 2024
-
Industrials: Sector Offers Investment Opportunities as Performance Lags Broader Market
-
Consumer Defensives: Even Amid Macro Pressures, Deals Permeate the Landscape
-
33 Undervalued Stocks
-
Utilities: Can the Stocks Keep the Rally Going?
-
Basic Materials: Following Index Decline, We See Many Long-Term Opportunities
-
Healthcare: Valuations Look Attractive In Most Industries
-
Financial Services: Amid Uncertainties, We See the Most Value In Banks and Credit Services
-
Consumer Cyclicals: Even With Anxiety Over Spending, We See Attractive Valuations